Now Available! | Check out UMR’s 2025 Annual Economic Report and State Toolkits today

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Labcorp, PerkinElmer latest to target COVID-flu combo test market

BD has a point-of-care antigen test, which received FDA emergency use authorization in March, that can rapidly test for both COVID-19 and influenza at the same time providing results in 15 minutes, as well as a PCR test that can be used in hospital laboratories.